Navigation Links
EntreMed to Present at BIO CEO and Investor Conference
Date:2/5/2008

ROCKVILLE, Md., Feb. 5 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that James S. Burns, President and Chief Executive Officer, will present a Corporate overview at the BIO CEO and Investor Conference, to be held at the Waldorf-Astoria Hotel, February 11-13, 2008. Mr. Burns' presentation is scheduled for Tuesday, February 12, 2008 at 2:45 p.m. (local time).

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

Mr. Burns' live presentation will be web cast and can be accessed through the Company's web site at http://www.entremed.com. An archive will be available on the web site for approximately 90 days.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. MKC-1 is currently in multiple Phase 2 clinical trials for cancer. MKC-1 is an oral cell-cycle regulator with activity against the mTOR pathway. Panzem(R) (2-methoxyestradiol) NCD is also in multiple Phase 2 studies in oncology patients. Additionally, ENMD-1198, a novel anticancer drug, is in Phase 1 studies in advanced cancers. The Company has approved IND applications for Panzem(R) in rheumatoid arthritis, and ENMD-2076, a dual-acting Aurora- angiogenesis inhibitor, for cancer. EntreMed's goal is to develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell-cycle regulation and inflammation -- processes vital to the treatment of ca
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study
2. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
3. EntreMed Appoints Senior Vice President of Research and Development
4. EntreMed to Present at ThinkEquity Partners 5th Annual Growth Conference
5. Echo Therapeutics to Present at RedChip Small-Cap Investor Conference
6. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
7. Sangamo BioSciences to Present at the BIO CEO & Investor Conference
8. Wyeth to Present at the Merrill Lynch 2008 Global Pharmaceutical, Biotechnology and Medical Device Conference
9. Emisphere Technologies to Present at BIO CEO & Investor Conference on February 12
10. inVentiv Health to Present at the 2008 UBS Global Healthcare Services Conference
11. Experts and Representatives From Leading International Health-Care Organizations Call to Stop the Hypertension Pandemic, a Worldwide Silent Killer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...yendpointhasbeenmetforpatientswithadvanced-stage,o....24/PRNewswire-FirstCall/-AEternaZentarisInc.(NASD...euticalcompanyfocusedonendocrinetherapyandoncology...ywithitstargetedcytotoxicpeptideconjugate,AEZS-108...endometrialcancer.Inapersonalizedhealthcareapproac...
(Date:11/24/2009)...r24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASDA...any,today,announcedthatithassubmittedaMAAtotheEuro...y,senzymereplacementtherapyindevelopment,forthetre...g,applicationforvelaglucerasealfathathasbeensubmit...nada. , Basedonaglobalsupplyshortageofthecurr...
(Date:11/24/2009)...lif.,Nov.24/PRNewswire-FirstCall/--GenomicHealth,I...omicHealth,sExecutiveChairman,willpresentatthe21st...yonTuesday,December1,2009at10:00a.m.ET. ,, Toac...entation,visittheInvestorRelationssectionofGenomic...m .Pleaseconnecttothewebsiteatleast15minutespriort...
(Date:11/24/2009)... Program Connects Customers with Partners Valid... DNA Genotek Products , O...k , a leading provider of products for biological ...today announced its new global partner program. Th...Genotek,s partner community and is designed to hel...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...organic light-emitting diodes, require a transpare...ning it promotes injection of electron holes into ...ch presented on July 8 at the International Confer... in Brazil provides insight into factors that infl...on of positive and negative charge carriers into t...
...d applications support in plant ...-Aldrich (Nasdaq:,SIAL) and Metahelix Life Science...lix will assist in developing applications data fo...nd provide expert technological guidance,regarding...ur in,Metahelix,s existing facility, located adjac...
... and pharmaceutical,firms are developing a host of...icated drug discovery process, reports Genetic Eng...sful approaches rely on a combination,of high-thro...es, and,advanced data-analysis tools, according to...ews.com/articles/chitem.aspx?aid=2527 ) of GEN., ...
Other Biology Technology:Research helps understand factors that influence efficiency of organic-based devices 2Research helps understand factors that influence efficiency of organic-based devices 3Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences 2Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences 3GEN Reports on Novel Hit-to-Lead Drug Discovery Strategies 2
(Date:11/25/2009)...olice officers and ambulance workers faced a terri...lex. They battled to save people from the collapsi...res and evacuated as many people as they could in .... And making their jobs even harder was the proble...heir relatives jammed mobile networks with calls a...
(Date:11/25/2009)...Soil is the linchpin of the environment, where atm...that, many students see soil as "just dirt" a pla...educators are challenged with the task of helping ...ortance of soil in the environment. , A collabo...eachers at University of Nebraska-Lincoln, Oregon ...
(Date:11/25/2009)...ant professors recently received funding from the ...arch beneficial to understanding the environment. ...lackwood, assistant professor in the Department of...t two separate research projects. , His first pr...ities and Functions from the Leaf to the Landscape...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3It's not just dirt! 2Kent State University professors focus research on the environment with grants totaling $890,000 2Kidney Care Partners Launches Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients 48197 1Kidney Care Partners Launches Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients 48197 2Kidney Care Partners Launches Health Care Campaign to Improve Survival Rates of First Year Dialysis Patients 48197 3U S Could Save 100 000 Lives a Year with Five Basic Preventive Services 48193 1U S Could Save 100 000 Lives a Year with Five Basic Preventive Services 48193 2Medical Home Pilot Initiatives Continue to Expand Nationwide 48189 1Medical Home Pilot Initiatives Continue to Expand Nationwide 48189 2Medical Home Pilot Initiatives Continue to Expand Nationwide 48189 3
...chool of Medicine and University of Crete School o... first evidence of a molecular mechanism that dyna...k connections. , This discovery may help the devel...s of normal aging, and for cognitive changes in sc...t hyperactivity disorder (ADHD). , "Our data re...
...chers have identified a novel gene mutation that c...was no previously known molecular diagnosis, accor...on Tuesday, March 20, 2007 in The American Journal...nd (Cambridge Institute of Medical Research, Unive...Tarpey (Wellcome Trust Sanger Institute, Hixton, U...
...ists at the University of California, San Diego an...a global map of estimated plant species richness. ...entists say their global map is the most extensive...to date. , The map, which accompanies a study publ...rnal Proceedings of the National Academy of Scienc...
Other Biology News:Brain networks strengthened by closing ion channels 2Brain networks strengthened by closing ion channels 3Severe mental retardation gene mutation identified 2Biologists produce global map of plant biodiversity 2
Goat Anti-Human p27 KIP 1 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Defender against cell death 1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Goat Anti-Wnt-1 (G-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Mouse Anti-Angiotensin II Type 1 Receptor Monoclonal Antibody, Unconjugated, Clone TONI-1 from Abcam
Biology Products: